NCT02083510View on ClinicalTrials.gov

Apolipoprotein CIII Reduction Via Colchicine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
HypertriglyceridemiaGoutPericarditis
Interventions
DRUG

Colchicine

Trial Locations (1)

92037

Scripps Translational Science Institute, La Jolla

All Listed Sponsors
lead

Scripps Translational Science Institute

OTHER

NCT02083510 - Apolipoprotein CIII Reduction Via Colchicine | Biotech Hunter | Biotech Hunter